You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ApoB-lipoproteins

Showing 1 - 25 of 324
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Familial Hypobetalipoproteinemia, Familial Hypobetalipoproteinemia - Heterozygous Form Trial (Administration of deuterated

Not yet recruiting
  • Familial Hypobetalipoproteinemia
  • Familial Hypobetalipoproteinemia - Heterozygous Form
  • Administration of deuterated compounds for kinetic study
  • (no location specified)
Oct 5, 2022

Type 2 Diabetes, Insulin Sensitivity/Resistance, Inflammatory Response Trial (Omega-3 fatty acids (2.7 g/d, EPA:DHA, 2:1))

Completed
  • Type 2 Diabetes
  • +3 more
  • Omega-3 fatty acids (2.7 g/d, EPA:DHA, 2:1)
  • (no location specified)
Aug 3, 2020

Atherogenic Lipoproteins in Ischemic Stroke

Recruiting
  • Ischemic Stroke
    • Basel, Switzerland
    • +1 more
    Oct 12, 2021

    Metabolic Syndrome Trial in Quebec (Monounsaturated fatty acids diet, Saturated fatty acids diet)

    Recruiting
    • Metabolic Syndrome
    • Monounsaturated fatty acids diet
    • Saturated fatty acids diet
    • Quebec, Canada
      Institute of Nutrition and Functional Foods (INAF)
    Aug 31, 2021

    Cardiovascular Diseases, Atherosclerosis, Lipoprotein(a) Trial (SLN360, Placebo)

    Not yet recruiting
    • Cardiovascular Diseases
    • +2 more
    • (no location specified)
    Sep 12, 2022

    Cholesterol Metabolism, Ketone Metabolism Trial in Vallejo (Standard American diet, Very low carbohydrate diet)

    Active, not recruiting
    • Cholesterol Metabolism
    • Ketone Metabolism
    • Standard American diet
    • Very low carbohydrate diet
    • Vallejo, California
      Touro University California
    Oct 4, 2021

    Hyperlipidemia Trial run by the (MCT oil + Butter in Coffee)

    Recruiting
    • Hyperlipidemia
    • MCT oil + Butter in Coffee
    • Bethesda, Maryland
      Walter Reed National Military Medical Center
    Oct 5, 2021

    Type 2 Diabetes, Inflammation, Insulin Sensitivity/Resistance Trial in Montréal (Omega-3 fatty acids)

    Recruiting
    • Type 2 Diabetes
    • +3 more
    • Omega-3 fatty acids
    • Montréal, Quebec, Canada
      Montreal Clinical Research Institute
    Aug 27, 2021

    Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,

    Not yet recruiting
    • Insulin Resistance
    • +3 more
    • Insulin human
    • +11 more
    • New York, New York
      Columbia University Irving Medical Center
    Nov 6, 2023

    Insulin Resistance, Prediabetic State, Hyperinsulinemia Trial in New York (drug, other, dietary supplement, device)

    Recruiting
    • Insulin Resistance
    • +4 more
    • Insulin human
    • +8 more
    • New York, New York
      Columbia University Irving Medical Center
    Feb 2, 2023

    Morbid Obesity Trial in Pierre-Bénite (Low-fat dairy products, Whole-fat dairy products, Milk polar lipid enriched whole-fat

    Not yet recruiting
    • Morbid Obesity
    • Low-fat dairy products
    • +2 more
    • Pierre-Bénite, France
    • +1 more
    Mar 23, 2023

    Hypobetalipoproteinemia Trial in Nantes (hypobetalipoproteinemia genetic and genotypic screening)

    Completed
    • Hypobetalipoproteinemia
    • hypobetalipoproteinemia genetic and genotypic screening
    • Nantes, France
      CHU de Nantes
    Feb 22, 2022

    Type 2 Diabetes Trial in Helsinki (Liraglutide, Placebo)

    Completed
    Has Results
    • Type 2 Diabetes
    • Helsinki, Finland
      Helsinki University Central Hospital
    Apr 11, 2022

    Hypercholesterolemia Trial in Worldwide (inclisiran sodium, Placebo)

    Active, not recruiting
    • Hypercholesterolemia
    • inclisiran sodium
    • Placebo
    • Lanzhou, Gansu, China
    • +44 more
    Feb 7, 2022

    Coronary Artery Disease, Coronary Atherosclerosis, Nicotine Dependence Trial in Warsaw (heated tobacco - lifestyle intervention)

    Not yet recruiting
    • Coronary Artery Disease
    • +2 more
    • heated tobacco - lifestyle intervention
    • Warsaw, Poland
      National Institute of Cardiology
    Dec 27, 2022

    ApoB48 Metabolism in Plasma and Interstitial Fluid

    Recruiting
    • Diabetes Mellitus, Type 2
      • Stockholm, Huddinge, Sweden
        Patient research centre, Clinic of endocrinology, Karolinska Uni
      May 27, 2021

      Type 2 Diabetes Trial in Helsinki (Evolocumab)

      Completed
      Has Results
      • Type 2 Diabetes Mellitus
      • Helsinki, Finland
        Helsinki University Hospital, Biomedicum 2U
      Oct 28, 2021

      Genetic Pathways Leading to Fatty Liver and Atherogenic

      Enrolling by invitation
      • Non-alcoholic Fatty Liver
      • +2 more
      • Lipoprotein kinetics
      • Helsinki, Finland
      • +1 more
      Apr 11, 2022

      Lipoprotein Metabolism in Normal Volunteers and High Levels of

      Completed
      • Hypolipoproteinemia
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 20, 2023

        Metabolic Syndrome Trial in Houston (Simvastatin, Vytorin, Placebo)

        Completed
        • Metabolic Syndrome
        • Houston, Texas
          Baylor College of Medicine
        Jul 21, 2022

        Cardiovascular Diseases Trial in Reus (Aged black garlic extract, Placebo)

        Completed
        • Cardiovascular Diseases
        • Aged black garlic extract
        • Placebo
        • Reus, Tarragona, Spain
          Centro Tecnológico de Nutrición y Salud (Eurecat-Reus)
        Feb 25, 2022

        Obesity, Metabolic Syndrome, Metabolism Disorder Trial in Seville (Lipid Emulsion)

        Active, not recruiting
        • Obesity
        • +4 more
        • Lipid Emulsion
        • Seville, Spain
          University of Seville
        Feb 16, 2023

        Dyslipidemia, Hypercholesterolemia Trial in Seoul (Test Meal)

        Completed
        Has Results
        • Dyslipidemia
        • Hypercholesterolemia
        • Test Meal
        • Seoul, Korea, Republic of
          MSD Korea Ltd.
        Feb 7, 2022

        Evaluation of Lipoproteins

        Active, not recruiting
        • Evaluation of Plasma Lipoproteins
        • Balanced diet
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 20, 2023

        Endocrine System Diseases, Nutritional and Metabolic Diseases, Diabetes, Type 2 Trial in Korea, Republic of (Rosuzet tablet 10/5

        Recruiting
        • Endocrine System Diseases
        • +3 more
        • Rosuzet tablet 10/5 mg (Ezetimibe 10 mg/Rosuvastatin 5 mg)
        • Ansan, Korea, Republic of
        • +27 more
        Jan 6, 2021